Laboratory Medicine ›› 2015, Vol. 30 ›› Issue (4): 367-375.DOI: 10.3969/j.issn.1673-8640.2015.04.018
Previous Articles Next Articles
ZHU Yang1, LU Zhongjiao2, FU Yi2
Received:
2014-10-29
Online:
2015-04-30
Published:
2015-05-16
CLC Number:
ZHU Yang, LU Zhongjiao, FU Yi. Correlation analysis of cerebral infarction with single nucleotide polymorphism of chromosome 9p21[J]. Laboratory Medicine, 2015, 30(4): 367-375.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2015.04.018
基因库号 | 引物序列(5'-3') | PCR产物长度(bp) |
---|---|---|
rs10757278 | ACTCTGTCTTGATTCTGCAT; TGAACTGAGGCCAGACAGG | 101 |
rs1333049 | TTGCTTACCTCTGCGAGTGG; ATGGTCACTACCCTACTGTC | 100 |
rs2383206 | CCTTACTATCCTGGTTGCCC; GTTCAGGATTCAGGCCATC | 100 |
rs1537378 | CCTGTTTCCAAATAGATTAC; TTCATCCATTAATAGCAAC | 99 |
rs4977574 | GGACATCTTTTGTTAGAGTG; GTTTGCTTTCAGGGTACATC | 91 |
rs2383207 | GGGACCATTTTTTACTCCTG; CAAGACATAACTAATAGCTG | 99 |
基因库号 | 引物序列(5'-3') | PCR产物长度(bp) |
---|---|---|
rs10757278 | ACTCTGTCTTGATTCTGCAT; TGAACTGAGGCCAGACAGG | 101 |
rs1333049 | TTGCTTACCTCTGCGAGTGG; ATGGTCACTACCCTACTGTC | 100 |
rs2383206 | CCTTACTATCCTGGTTGCCC; GTTCAGGATTCAGGCCATC | 100 |
rs1537378 | CCTGTTTCCAAATAGATTAC; TTCATCCATTAATAGCAAC | 99 |
rs4977574 | GGACATCTTTTGTTAGAGTG; GTTTGCTTTCAGGGTACATC | 91 |
rs2383207 | GGGACCATTTTTTACTCCTG; CAAGACATAACTAATAGCTG | 99 |
组别 | 年龄 (岁) | 男性 [例数(%)] | 高脂血症 [例数(%)] | TC (mmol/L) | HDL-C (mmol/L) | LDL-C (mmol/L) |
---|---|---|---|---|---|---|
脑梗死组 | ||||||
无颈动脉斑块组 | 56.56±7.65 | 96(62.70) | 52(34.00) | 4.60±1.12 | 1.22±0.40 | 2.86±0.90 |
有颈动脉斑块组 | 56.34±7.85* | 127(49.20) | 79(30.60) | 4.68±0.96 | 1.35±1.42* | 2.80±0.80 |
正常对照组 | 60.90±6.24 | 256(68.30)* | 148(39.50) | 4.50±1.33 | 1.12±0.35 | 3.02±0.93 |
组别 | TG (mmol/L) | 糖尿病 [例数(%)] | 空腹血糖 (mmol/L) | 高血压 [例数(%)] | 收缩压 (kPa) | 舒张压 (kPa) |
脑梗死组 | ||||||
无颈动脉斑块组 | 1.90±1.21 | 23(15.00) | 5.78±2.19 | 81(52.90) | 18.4±2.8 | 11.1±1.6 |
有颈动脉斑块组 | 1.91±1.46 | 29(11.20)* | 5.51±1.46* | 84(36.40)* | 17.6±2.1* | 10.5±1.3 |
正常对照组 | 2.04±1.34 | 86(22.90) | 6.24±2.82 | 246(65.60)* | 18.9±2.5* | 11.1±1.5* |
组别 | 年龄 (岁) | 男性 [例数(%)] | 高脂血症 [例数(%)] | TC (mmol/L) | HDL-C (mmol/L) | LDL-C (mmol/L) |
---|---|---|---|---|---|---|
脑梗死组 | ||||||
无颈动脉斑块组 | 56.56±7.65 | 96(62.70) | 52(34.00) | 4.60±1.12 | 1.22±0.40 | 2.86±0.90 |
有颈动脉斑块组 | 56.34±7.85* | 127(49.20) | 79(30.60) | 4.68±0.96 | 1.35±1.42* | 2.80±0.80 |
正常对照组 | 60.90±6.24 | 256(68.30)* | 148(39.50) | 4.50±1.33 | 1.12±0.35 | 3.02±0.93 |
组别 | TG (mmol/L) | 糖尿病 [例数(%)] | 空腹血糖 (mmol/L) | 高血压 [例数(%)] | 收缩压 (kPa) | 舒张压 (kPa) |
脑梗死组 | ||||||
无颈动脉斑块组 | 1.90±1.21 | 23(15.00) | 5.78±2.19 | 81(52.90) | 18.4±2.8 | 11.1±1.6 |
有颈动脉斑块组 | 1.91±1.46 | 29(11.20)* | 5.51±1.46* | 84(36.40)* | 17.6±2.1* | 10.5±1.3 |
正常对照组 | 2.04±1.34 | 86(22.90) | 6.24±2.82 | 246(65.60)* | 18.9±2.5* | 11.1±1.5* |
年龄 (岁) | 组别 | rs10757278 | rs1333049 | rs2383206 | |||
---|---|---|---|---|---|---|---|
G | A | C | G | G | A | ||
<45 | 脑梗死组 | 13(54.2) | 11(45.8) | 13(54.2) | 11(45.8) | 13(54.2) | 11(45.8) |
正常对照组 | 14(36.8) | 24(63.2) | 14(36.8) | 24(63.2) | 14(36.8) | 24(63.2) | |
P值 | 0.376 | 0.376 | 0.376 | ||||
OR值(95%CI) | 1.659(0.541~5.085) | 1.658(0.541~5.076) | 0.603(0.197~1.848) | ||||
45~65 | 脑梗死组 | 129(54.2) | 109(45.8) | 129(54.2) | 109(45.8) | 131(55.0) | 107(45.0) |
正常对照组 | 191(46.6) | 219(53.4) | 191(46.6) | 219(53.4) | 188(45.9) | 222(54.1) | |
P值 | 0.052 | 0.054 | 0.021 | ||||
OR值(95%CI) | 1.383(0.997~1.923) | 1.381(0.995~1.917) | 1.472(1.060~2.044) | ||||
>65 | 脑梗死组 | 18(40.9) | 26(59.1) | 18(40.9) | 26(59.1) | 15(34.1) | 29(65.9) |
正常对照组 | 35(51.5) | 33(48.5) | 35(51.5) | 33(48.5) | 35(51.5) | 33(48.5) | |
P值 | 0.242 | 0.276 | 0.055 | ||||
OR值(95%CI) | 0.596(0.251~1.419) | 0.619(0.262~1.466) | 0.418(0.172~1.020) | ||||
年龄 (岁) | 组别 | rs1537378 | rs4977574 | rs2383207 | |||
T | C | G | A | G | A | ||
<45 | 脑梗死组 | 4(16.7) | 20(83.3) | 13(54.2) | 11(45.8) | 18(75.0) | 6(25.0) |
正常对照组 | 10(26.3) | 28(73.7) | 14(36.8) | 24(63.2) | 22(57.9) | 16(42.1) | |
P值 | 0.561 | 0.376 | 0.170 | ||||
OR值(95%CI) | 0.664(0.167~2.639) | 0.603(0.197~1.848) | 2.320(0.698~7.708) | ||||
45~65 | 脑梗死组 | 30(12.6) | 208(87.4) | 129(54.2) | 109(45.8) | 165(69.3) | 73(30.7) |
正常对照组 | 67(16.3) | 343(83.7) | 182(44.4) | 228(55.6) | 267(65.1) | 143(34.9) | |
P值 | 0.176 | 0.013 | 0.239 | ||||
OR值(95%CI) | 0.722(0.449~1.157) | 1.519(1.094~2.110) | 1.235(0.869~1.754) | ||||
>65 | 脑梗死组 | 5(11.4) | 39(88.6) | 16(36.4) | 28(63.6) | 26(59.1) | 18(40.9) |
正常对照组 | 8(11.8) | 60(88.2) | 34(50.0) | 34(50.0) | 48(70.6) | 20(29.4) | |
P值 | 0.712 | 0.160 | 0.326 | ||||
OR值(95%CI) | 0.783(0.214~2.867) | 0.534(0.222~1.282) | 0.639(0.261~1.562) |
年龄 (岁) | 组别 | rs10757278 | rs1333049 | rs2383206 | |||
---|---|---|---|---|---|---|---|
G | A | C | G | G | A | ||
<45 | 脑梗死组 | 13(54.2) | 11(45.8) | 13(54.2) | 11(45.8) | 13(54.2) | 11(45.8) |
正常对照组 | 14(36.8) | 24(63.2) | 14(36.8) | 24(63.2) | 14(36.8) | 24(63.2) | |
P值 | 0.376 | 0.376 | 0.376 | ||||
OR值(95%CI) | 1.659(0.541~5.085) | 1.658(0.541~5.076) | 0.603(0.197~1.848) | ||||
45~65 | 脑梗死组 | 129(54.2) | 109(45.8) | 129(54.2) | 109(45.8) | 131(55.0) | 107(45.0) |
正常对照组 | 191(46.6) | 219(53.4) | 191(46.6) | 219(53.4) | 188(45.9) | 222(54.1) | |
P值 | 0.052 | 0.054 | 0.021 | ||||
OR值(95%CI) | 1.383(0.997~1.923) | 1.381(0.995~1.917) | 1.472(1.060~2.044) | ||||
>65 | 脑梗死组 | 18(40.9) | 26(59.1) | 18(40.9) | 26(59.1) | 15(34.1) | 29(65.9) |
正常对照组 | 35(51.5) | 33(48.5) | 35(51.5) | 33(48.5) | 35(51.5) | 33(48.5) | |
P值 | 0.242 | 0.276 | 0.055 | ||||
OR值(95%CI) | 0.596(0.251~1.419) | 0.619(0.262~1.466) | 0.418(0.172~1.020) | ||||
年龄 (岁) | 组别 | rs1537378 | rs4977574 | rs2383207 | |||
T | C | G | A | G | A | ||
<45 | 脑梗死组 | 4(16.7) | 20(83.3) | 13(54.2) | 11(45.8) | 18(75.0) | 6(25.0) |
正常对照组 | 10(26.3) | 28(73.7) | 14(36.8) | 24(63.2) | 22(57.9) | 16(42.1) | |
P值 | 0.561 | 0.376 | 0.170 | ||||
OR值(95%CI) | 0.664(0.167~2.639) | 0.603(0.197~1.848) | 2.320(0.698~7.708) | ||||
45~65 | 脑梗死组 | 30(12.6) | 208(87.4) | 129(54.2) | 109(45.8) | 165(69.3) | 73(30.7) |
正常对照组 | 67(16.3) | 343(83.7) | 182(44.4) | 228(55.6) | 267(65.1) | 143(34.9) | |
P值 | 0.176 | 0.013 | 0.239 | ||||
OR值(95%CI) | 0.722(0.449~1.157) | 1.519(1.094~2.110) | 1.235(0.869~1.754) | ||||
>65 | 脑梗死组 | 5(11.4) | 39(88.6) | 16(36.4) | 28(63.6) | 26(59.1) | 18(40.9) |
正常对照组 | 8(11.8) | 60(88.2) | 34(50.0) | 34(50.0) | 48(70.6) | 20(29.4) | |
P值 | 0.712 | 0.160 | 0.326 | ||||
OR值(95%CI) | 0.783(0.214~2.867) | 0.534(0.222~1.282) | 0.639(0.261~1.562) |
组别 | GG*±GG# | (GA+AA)*+GG# | GG*+(GA+AA)# | (GA+AA)*+(GA+AA)# |
---|---|---|---|---|
无颈动脉斑块的脑梗死组 | 40(26.1) | 1(0.7) | 2(1.3) | 110(71.9) |
正常对照组 | 46(17.8) | 1(0.4) | 5(1.9) | 206(79.8) |
OR值(95%CI) | 1.271(0.072~22.220) | 3.174(0.566~17.860) | 1.733(1.056~2.849) | |
P值 | 0.870 | 0.189 | 0.030 |
组别 | GG*±GG# | (GA+AA)*+GG# | GG*+(GA+AA)# | (GA+AA)*+(GA+AA)# |
---|---|---|---|---|
无颈动脉斑块的脑梗死组 | 40(26.1) | 1(0.7) | 2(1.3) | 110(71.9) |
正常对照组 | 46(17.8) | 1(0.4) | 5(1.9) | 206(79.8) |
OR值(95%CI) | 1.271(0.072~22.220) | 3.174(0.566~17.860) | 1.733(1.056~2.849) | |
P值 | 0.870 | 0.189 | 0.030 |
[1] | DELLA-Morte D, GUADAGNI F, PALMIROTTA R, et al.Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments[J]. Pharmacogenomics,2012,13(5):595-613. |
[2] | FLOSSMANN E, SCHULZ UG, ROTHWELL PM.Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke[J]. Stroke,2004,35(1):212-227. |
[3] | MCPHERSON R, PERTSEMLIDIS A, KAVASLAR N, et al.A common allele on chromosome 9 associated with coronary heart disease[J]. Science,2007,316(5830):1488-1491. |
[4] | SAMANI NJ, ERDMANN J, HALL AS, et al.Genomewide association analysis of coronary artery disease[J]. N Engl J Med,2007,357(5):443-453. |
[5] | SCHEFFOLD T, KULLMANN S, HUGE A, et al.Six sequence variants on chromosome 9p21.3 are associated with a positive family history of myocardial infarction: a multicenter registry[J]. BMC Cardiovasc Disord,2011,11(7):9. |
[6] | ANDERSON CD, BIFFI A, ROST NS, et al.Chromosome 9p21 in ischemic stroke: population structure and meta-analysis[J]. Stroke,2010,41(6):1123-1131. |
[7] | GSCHWENDTNER A, BEVAN S, COLE JW, et al.Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke[J]. Ann Neurol,2009,65(5):531-539. |
[8] | ZHANG Z, WANG BJ, GUAN HY, et al.A LDR-PCR approach for multiplex polymorphisms genotyping of severely degraded DNA with fragment sizes<100 bp[J]. J Forensic Sci,2009,54(6):1304-1309. |
[9] | HECKMAN MG, SOTO-ORTOLAZA AI, DIEHL NN, et al.Genetic variants associated with myocardial infarction in the PSMA6 gene and Chr9p21 are also associated with ischaemic stroke[J]. Eur J Neurol,2013,20(2):300-308. |
[10] | LÖVKVIST H, SJÖGREN M, HÖGLUND P, et al. Are 25 SNPs from the CARDIoGRAM study associated with ischaemic stroke[J]. Eur J Neurol,2013,20(9):1284-1291. |
[11] | TRAYLOR M, FARRALL M, HOLLIDAY EG, et al.Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies[J]. Lancet Neurol,2012,11(11):951-962. |
[12] | SMITH JG, MELANDER O, LÖVKVIST H, et al. Common genetic variants on chromosome 9p21 confers risk of ischemic stroke: a large-scale genetic association study[J]. Circ Cardiovasc Genet,2009,2(2):159-164. |
[13] | The group of guidelines for acute ischemic stroke in Chinese Medical Association. Guidelines for acute ischemic stroke in China of 2010[J]. China Medical News,2010,25(14):16-19. |
[14] | ADAMS HP, BENDIXEN BH, KAPPELLE LJ, et al.Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment[J]. Stroke, 1993,24(1):35-41. |
[15] | STEIN JH, KORCARZ CE, HURST RT, et al.Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine[J]. J Am Soc Echocardiogr,2008,21(2):93-111. |
[16] | SCHULZ UG, FLOSSMANN E, ROTHWELL PM.Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies[J]. Stroke,2004,35(4):819-824. |
[17] | OLSSON S, JOOD K, BLOMSTRAND C, et al.Genetic variation on chromosome 9p21 shows association with the ischaemic stroke subtype large-vessel disease in a Swedish sample aged≤70[J]. Eur J Neurol,2011,18(2):365-367. |
[18] | SHI YY, HE L.SHESIS, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci[J]. Cell Res, 2005,15(2):97-98. |
[19] | KRUGLYAK L.Prospects for whole-genome linkage disequilibrium mapping of common disease genes[J]. Nat genet, 1999,22(2):139-144. |
[20] | JARINOVA O, STEWART AF, ROBERTS R, et al.Functional analysis of the chromosome 9p21. 3 coronary artery disease risk locus[J]. Arterioscler Tromb Vasc Bio,2009,29(10):1671-1677. |
[21] | BURD CE, JECK WR, LIU Y, et al.Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk[J]. PLoS Genet,2010,6(12):e1001233. |
[22] | VISEL A, ZHU Y, MAY D, et al.Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice[J]. Nature,2010,464(7287):409-412. |
[23] | HU WL, LI SJ, LIU DT, et al.Genetic variants on chromosome 9p21 and ischemic stroke in Chinese[J]. Brain Res Bull,2009,79(6):431-435. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||